A practical guide to basic laboratory andrology

A Practical Guide to Basic Laboratory Andrology

Volumn , Issue , 2010, Pages 1-336

  Björndahl, Lars ^a   Mortimer, David ^b   Barratt, Christopher L R ^c   Castilla, Jose Antonio ^d   Menkveld, Roelof ^e   Kvist, Ulrik ^a   Alvarez, Juan G ^f   Haugen, Trine B ^g  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Oozoa Biomedical Inc   (Canada)

^c UNIVERSITY OF DUNDEE   (United Kingdom)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^e STELLENBOSCH UNIVERSITY   (South Africa)

^f Instituto Marques   (Spain)

^g OSLO METROPOLITAN UNIVERSITY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932640553     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511729942     Document Type: Book

References (387)

1. Hull MG, Glazener CM, Kelly NJ, et al. Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 1985; 291: 1693–7.
2. Andersen AG, Jensen TK, Carlsen E, et al. High frequency of sub-optimal semen quality in an unselected population of young men. Hum Reprod 2000; 15: 366–72.
3. Sharpe RM, Irvine DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ 2004; 328: 447–51.
4. Björndahl L, Barratt CL. Semen analysis: setting standards for the measurement of sperm numbers. J Androl 2005; 26: 11.
5. Riddell D, Pacey A, Whittington K. Lack of compliance by UK andrology laboratories with World Health Organization recommendations for sperm morphology assessment. Hum Reprod 2005; 20: 3441–5.
6. Keel BA. Within-and between-subject variation in semen parameters in infertile men and normal semen donors. Fertil Steril 2006; 85: 128–34.
7. Castilla JA, Alvarez C, Aguilar J, et al. Influence of analytical and biological variation on the clinical interpretation of seminal parameters. Hum Reprod 2006; 21: 847–51.
8. Stokes-Riner A, Thurston SW, Brazil C, et al. One semen sample or 2? Insights from a study of fertile men. J Androl 2007; 28: 638–43.
9. Hirsh A. Male subfertility. BMJ 2003; 327: 669–72.
10. Mishail A, Marshall S, Schulsinger D, Sheynkin Y. Impact of a second semen analysis on a treatment decision making in the infertile man with varicocele. Fertil Steril 2009; 91: 1809–11.
11. Guzick DS, Overstreet JW, Factor-Litvak P, et al. National Cooperative Reproductive Medicine Network. Sperm morphology, motility, and concentration in fertile and infertile men. N Engl J Med 2001; 345: 1388–93.
12. Jedrzejczak P, Taszarek-Hauke G, Hauke J, et al. Prediction of spontaneous conception based on semen parameters. Int J Androl 2008; 31: 499–507.
13. van Weert JM, Repping S, Van Voorhis BJ, et al. Performance of the postwash total motile sperm count as a predictor of pregnancy at the time of intrauterine insemination: a meta-analysis. Fertil Steril 2004; 82: 612–20.
14. Jequier AM. The importance of diagnosis in the clinical management of infertility in the male. Reprod Biomed Online 2006; 13: 331–5.
15. Kvist U, Björndahl L, eds. Manual on Basic Semen Analysis. Oxford: Oxford University Press 2002.
16. Mortimer D. Practical Laboratory Andrology. Oxford: Oxford University Press 1994.
17. Pound N, Javed MH, Ruberto C, et al. Duration of sexual arousal predicts semen parameters for masturbatory ejaculates. Physiol Behav 2002; 76: 685–9.
18. Zavos PM, Goodpasture JC. Clinical improvements of specific seminal deficiencies via intercourse with a seminal collection device versus masturbation. Fertil Steril 1989; 51: 190–3.
19. Kamischke A, Nieschlag E. Treatment of retrograde ejaculation and anejaculation. Hum Reprod Update 1999; 5: 448–74.
20. MacLeod J, Gold RZ. The male factor in fertility and infertility. V. Effect of continence on semen quality. Fertil Steril 1952; 3: 297–315.
21. Carlsen E, Andersson AM, Petersen JH, Skakkebaek NE. History of febrile illness and variation in semen quality. Hum Reprod 2003; 18: 2089–92.
22. Cooper TG, Brazil C, Swan SH, Overstreet JW. Ejaculate volume is seriously underestimated when semen is pipetted or decanted into cylinders from the collection vessel. J Androl 2007; 28: 1–4.
23. Björndahl L, Kvist U. Sequence of ejaculation affects the spermatozoon as a carrier and its message. Reprod Biomed Online 2003; 7: 440–8.
24. MacLeod J, Gold RZ. The male factor in fertility and infertility. III. An analysis of motile activity in the spermatozoa of 1000 fertile men and 1000 men in infertile marriage. Fertil Steril 1951; 2: 187–204.
25. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge, UK: Cambridge University Press 1999.
26. Mortimer D. Laboratory standards in routine clinical andrology. Reproductive Medicine Review 1994; 3: 97–111.
27. Sifer C, Sasportes T, Barraud V, et al. World Health Organization grade ‘a’ motility and zona-binding test accurately predict IVF outcome for mild male factor and unexplained infertilities. Hum Reprod 2005; 20: 2769–75.
28. Verheyen G, Tournaye H, Staessen C, et al. Controlled comparison of conventional in-vitro fertilization and intracytoplasmic sperm injection in patients with asthenozoospermia. Hum Reprod 1999; 14: 2313–19.
29. Kirkman Brown J, Björndahl L. Evaluation of a disposable plastic Neubauer counting chamber for semen analysis. Fertil Steril 2009; 91: 627–31.
30. Björndahl L, Söderlund I, Johansson S, et al. Why the WHO recommendations for eosinnigrosin staining techniques for human sperm vitality assessment must change. J Androl 2004; 25: 671–8.
31. Björndahl L, Söderlund I, Kvist U. Evaluation of the one-step eosin-nigrosin staining technique for human sperm vitality assessment. Hum Reprod 2003; 18: 813–16.
32. Hühner M. Methods of examining for spermatozoa in the diagnosis and treatment of sterility. Int J Surg 1921; 34: 91–100.
33. Cary WH. Sterility diagnosis: The study of sperm cell migration in female secretion and interpretation of findings. NY State J Med 1930; 30: 131–6.
34. Cary WH, Hotchkiss RS. Semen appraisal. Adifferential stain that advances the study of cell morphology. JAMA 1934; 102: 587–90.
35. Moench GL, Holt H. Biometrical studies of head lengths of human spermatozoa. J Lab Clin Med 1932; 17: 297–316.
36. Menkveld R. An investigation of environmental influences on spermatogenesis and semen parameters. Ph.D. dissertation, Faculty of Medicine, University of Stellenbosch, South Africa, 1987.
37. Menkveld R, Stander FSH, Kotze TJ vW, et al. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 1990; 5: 586–92.
38. Coetzee K, Kruger TF, Lombard CJ. Predictive value of normal sperm morphology: a structured literature review. Hum Reprod Update 1998; 4: 73–82.
39. Menkveld R. Chapter 9. The basic semen analysis. In: Oehninger S, Kruger TF, eds. Male Infertility. Oxon: Informa Healthcare 2007: 141–70.
40. Papanicolaou GN. A new procedure for staining vaginal smears. Science 1942; 95: 438–9.
41. Oettlé EE. Using a new acrosome stain to evaluate sperm morphology. Vet Med 1986; 81: 263–6.
42. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd edn. Cambridge, UK: Cambridge University Press 1992.
43. Oettlé EE, Menkveld R, Swanson RJ. Photographs with interpretations. In: Menkveld R, Oettlé EE, Kruger TF, et al., eds. Atlas of Human Sperm Morphology. Baltimore, MD: Williams & Wilkins 1991: 15–65.
44. Cooper TG, Yeung CH, Fetic S, et al. Cytoplasmic droplets are normal structures of human sperm but are not well preserved by routine procedures for assessing sperm morphology. Hum Reprod 2004; 19: 2283–8.
45. Kruger TF, Acosta AA, Simmons KF, et al. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988; 49: 112–17.
46. Schaefer HE, Fischer R. {Specific staining of eosinophilic granulocytes with Biebrich scarlet}. Klin Wochenschr 1968; 46: 396–7.
47. Lackner J, Schatzl G, Horvath S, et al. Value of counting white blood cells (WBC) in semen samples to predict the presence of bacteria. Eur Urol 2006; 49: 148–52; discussion 52–3.
48. Punab M, Loivukene K, Kermes K, Mandar R. The limit of leucocytospermia from the microbiological viewpoint. Andrologia 2003; 35: 271–8.
49. Rodin DM, Larone D, Goldstein M. Relationship between semen cultures, leukospermia, and semen analysis in men undergoing fertility evaluation. Fertil Steril 2003; 79 Suppl 3: 1555–8.
50. Bedford JM, Zelikovsky G. Viability of spermatozoa in the human ejaculate after vasectomy. Fertil Steril 1979; 32: 460–3.
51. Lewis EL, Brazil CK, Overstreet JW. Human sperm function in the ejaculate following vasectomy. Fertil Steril 1984; 42: 895–8.
52. Jouannet P, David G. Evolution of the properties of semen immediately following vasectomy. Fertil Steril 1978; 29: 435–41.
53. Hancock P, McLaughlin E. British Andrology Society guidelines for the assessment of post vasectomy semen samples (2002). J Clin Pathol 2002; 55: 812–16.
54. Chamley LW, Clarke GN. Antisperm antibodies and conception. Semin Immunopathol. 2007; 29: 169–84.
55. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 2009; in press.
56. Chiu WW, Chamley LW. Clinical associations and mechanisms of action of antisperm antibodies. Fertil Steril 2004; 82: 529–35.
57. Lombardo F, Gandini L, Lenzi A, Dondero F. Antisperm immunity in assisted reproduction. J Reprod Immunol 2004; 62: 101–9.
58. Barratt CL, Dunphy BC, McLeod I, Cooke ID. The poor prognostic value of low to moderate levels of sperm surface-bound antibodies. Hum Reprod 1992; 7: 95–8.
59. Helmerhorst FM, Finken MJ, Erwich JJ. Antisperm antibodies: detection assays for antisperm antibodies: what do they test? Hum Reprod 1999; 14: 1669–71.
60. Hjort T. Antisperm antibodies. Antisperm antibodies and infertility: an unsolvable question? Hum Reprod 1999; 14: 2423–6.
61. Mahmoud A, Comhaire F. Antisperm antibodies: use of the mixed agglutination reaction (MAR) test using latex beads. Hum Reprod 2000; 15: 231–3.
62. Meinertz H, Linnet L, Fogh-Andersen P, Hjort T. Antisperm antibodies and fertility after vasovasostomy: a follow-up study of 216 men. Fertil Steril 1990; 54: 315–21.
63. Bronson RA, Cooper GW, Rosenfeld DL. Sperm-specific isoantibodies and autoantibodies inhibit the binding of human sperm to the human zona pellucida. Fertil Steril 1982; 38: 724–9.
64. Matson PL. External quality assessment for semen analysis and sperm antibody detection: results of a pilot scheme. Hum Reprod 1995; 10: 620–5.
65. Bohring C, Krause W. Interlaboratory variability of the indirect mixed antiglobulin reaction in the assessment of antisperm antibodies. Fertil Steril 2002; 78: 1336–8.
66. Mortimer D. Practical Laboratory Andrology. New York: Oxford University Press 1994.
67. Keck C, Gerber-Schäfer C, Clad A, et al. Seminal tract infections: impact on male fertility and treatment options. Hum Reprod Update 1998; 4: 891–903.
68. Weidner W, Krause W, Ludwig M. Relevance of male accessory gland infection for subsequent fertility with special focus on prostatitis. Hum Reprod Update 1999; 5: 421–32.
69. Elder K, Baker D, Ribes J. Infections, Infertility and Assisted Reproduction. Cambridge, UK: Cambridge University Press 2005.
70. Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia 2008; 40: 72–5.
71. Eggert-Kruse W, Kiefer I, Beck C, et al. Role for tumor necrosis factor alpha (TNF-alpha) and interleukin 1-beta (IL-1beta) determination in seminal plasma during infertility investigation. Fertil Steril 2007; 87: 810–23.
72. Politch JA, Tucker L, Bowman FP, et al. Concentrations and significance of cytokines and other immunologic factors in semen of healthy fertile men. Hum Reprod 2007; 22: 2928–35.
73. Bezold G, Politch JA, Kiviat NB, et al. Prevalence of sexually transmissible pathogens in semen from asymptomatic male infertility patients with and without leukocytospermia. Fertil Steril 2007; 87: 1087–97.
74. Tomlinson MJ, Barratt CL, Cooke ID. Prospective study of leukocytes and leukocyte subpopulations in semen suggests they are not a cause of male infertility. Fertil Steril 1993; 60: 1069–75.
75. Aitken RJ, Buckingham D, West K, Wu FC, Zikopoulos K, Richardson DW. Differential contribution of leukocytes and spermatozoa to the generation of reactive oxygen species in the ejaculates of oligozoospermic patients and fertile donors. J Reprod Fertil 1992; 94: 451–62.
76. Aitken RJ, West K, Buckingham D. Leukocytic infiltration into the human ejaculate and its association with semen quality, oxidative stress, and sperm function. J Androl 1994; 15: 343–52.
77. Tomlinson MJ, White A, Barratt CL, Bolton AE, Cooke ID. The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocytes? Hum Reprod 1992; 7: 517–22.
78. Comhaire F, Verschraegen G, Vermeulen L. Diagnosis of accessory gland infection and its possible role in male infertility. Int J Androl 1980; 3: 32–45.
79. Eggert-Kruse W, Zimmermann K, Geißler W, Ehrmann A, Boit R, Strowitzki T. Clinical relevance of polymorphonuclear (PMN-) elastase determination in semen and serum during infertility investigation. Int J Androl 2009; 32: 317–29.
80. Nahoum CR, Cardozo D. Staining for volumetric count of leukocytes in semen and prostate-vesicular fluid. Fertil Steril 1980; 34: 68–9.
81. Tomlinson MJ, Barratt CL, Bolton AE, Lenton EA, Roberts HB, Cooke ID. Round cells and sperm fertilizing capacity: the presence of immature germ cells but not seminal leukocytes are associated with reduced success of in vitro fertilization. Fertil Steril 1992; 58: 1257–9.
82. Johnsen Ø, Eliasson R, Evaluation of a commercially available kit for the colorimetric determination of zinc in human seminal plasma. Int J Androl 1987; 10: 435–40.
83. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge, UK: Cambridge University Press 1999.
84. Cooper TG, Weidner W, Nieschlag E. The Influence of inflammation of the human male genital tract on secretion of the seminal markers a-glucosidase, glycerophosphocholine, carnitine, fructose and citric acid. Int J Androl 1990; 13: 329–36.
85. Dreden P, Richard P, Gonzales J. Fructose and proteins in human semen. Andrologia 1989; 21: 576–9.
86. Jungreis E, Nechama M, Paz G, Homonai T. A simple spot test for the detection of fructose deficiency in semen. Int J Androl 1989; 12: 195–8.
87. Paquin R, Chapdelaine R, Dube JY, Tremblay RR. Similar biochemical properties of human seminal plasma and epididymal α-1, 4-glucosidase. J Androl 1984; 5: 277–82.
88. Cooper TG, Yeung CH, Nashan D, et al. Improvement in the assessment of human epididymal function by the use of inhibitors in the assay of α-glucosidase in seminal plasma. Int J Androl 1990; 13: 297–305.
89. MacLeod J, Gold RZ. The male factor in fertility and infertility. III. An analysis of motile activity in the spermatozoa of 1000 fertile men and 1000 men in infertile marriage. Fertil Steril 1951; 2: 187–204.
90. Lindholmer C. Survival of human spermatozoa in different fractions of split ejaculate. Fertil Steril 1973; 24: 521–6.
91. Björndahl L, Kjellberg S, Kvist U. Ejaculatory sequence in men with low sperm chromatinzinc. Int J Androl 1991; 14: 174–8.
92. Björndahl L, Kvist U. Influence of seminal vesicular fluid on the zinc content of human sperm chromatin. Int J Androl 1990; 13: 232–7.
93. Björndahl L, Kvist U. Sequence of ejaculation affects the spermatozoon as a carrier and its message. RBM Online 2003; 7: 440–8.
94. Davis RO, Katz DF. Computer-aided sperm analysis: technology at a crossroads. Fertil Steril 1993; 59: 953–5.
95. Boyers SP, Davis RO, Katz DF. Automated semen analysis. Curr Probl Obstet Gynecol Fertil 1989; XII: 167–200.
96. Mortimer ST. A critical review of the physiological importance and analysis of sperm movement in mammals. Hum Reprod Update 1997; 3: 403–39.
97. Mortimer D, Mortimer ST. Value and reliability of CASA systems. In: Ombelet W, Bosmans E, Vandeput H, et al., eds. Modern ART in the 2000s. Carnforth: Parthenon Publishing 1998.
98. Mortimer ST. CASA–practical aspects. J Androl 2000; 21: 515–24.
99. Mortimer D, Aitken RJ, Mortimer ST, Pacey AA. Workshop report: clinical CASA – the quest for consensus. Reprod Fertil Dev 1995; 7: 951–9.
100. ESHRE Andrology Special Interest Group. Consensus workshop on advanced diagnostic andrology techniques. Hum Reprod 1996; 11: 1463–79.
101. ESHRE Andrology Special Interest Group. Guidelines on the application of CASA technology in the analysis of spermatozoa. Hum Reprod 1998; 13: 142–5.
102. Serres C, Feneux D, Jouannet P, David G. Influence of the flagellar wave development and propagation on the human sperm movement in seminal plasma. Gamete Res 1984; 9: 183–95.
103. Mortimer D, Serres C, Mortimer ST, Jouannet P. Influence of image sampling frequency on the perceived movement characteristics of progressively motile human spermatozoa. Gamete Res 1988; 20: 313–27.
104. Zinaman MJ, Uhler ML, Vertuno E, et al. Evaluation of computer-assisted semen analysis (CASA) with IDENT stain to determine sperm concentration. J Androl 1996; 17: 288–92.
105. Irvine DS, Macleod IC, Templeton AA, et al. A prospective clinical study of the relationship between the computer-assisted assessment of human semen quality and the achievement of pregnancy in vivo. Hum Reprod 1994; 9: 2324–34.
106. Macleod IC, Irvine DS. The predictive value of computer-assisted semen analysis in the context of a donor insemination programme. Hum Reprod 1995; 10: 580–6.
107. Mortimer D, Mortimer ST. Laboratory investigation of the infertile male. In: Brinsden PR, edn. A Textbook of In-Vitro Fertilization and Assisted Reproduction. 3rd edn. London: Taylor & Francis Medical Books 2005: 61–91.
108. Mortimer ST, Swan MA. Effect of image sampling frequency on established and smoothing-independent kinematic values of capacitating human spermatozoa. J Androl 1999; 14: 997–1004.
109. ESHRE Andrology Special Interest Group. Consensus workshop on advanced diagnostic andrology techniques. Hum Reprod 1996; 11: 1463–79.
110. Alvarez JG, Storey BT. Spontaneous lipid peroxidation in rabbit epididymal spermatozoa. Biol Reprod 1982; 27: 1102–8.
111. Holland MK, Alvarez JG, Storey BT. Production of superoxide and activity of superoxide dismutase in rabbit epididymal spermatozoa. Biol Reprod 1982; 27: 1109–18.
112. Alvarez JG, Storey BT. Lipid peroxidation and the reactions of superoxide and hydrogen peroxide in mouse spermatozoa. Biol Reprod 1984; 30: 833–41.
113. Alvarez JG, Touchstone JC, Blasco, L, Storey BT. Spontaneous lipid peroxidation and production of hydrogen peroxide and superoxide in human spermatozoa. Superoxide dismutase as major enzyme protectant against oxygen toxicity. J Androl 1987; 8: 338–48.
114. Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil 1987; 81: 459–69.
115. Alvarez JG, Storey BT. Differential incorporation of fatty acids into and peroxidative loss of fatty acids from phospholipids of human spermatozoa. Mol Reprod Dev 1995; 42: 334–46.
116. Fraga CG, Motchnik PA, Shigenaga MK, et al. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci USA 1991; 88: 11003–6.
117. Fraga CG, Motchnik PA, Wyrobek AJ, et al. Smoking and low antioxidant levels increase oxidative damage to sperm DNA. Mutat Res 1996; 351: 199–203.
118. Ollero M, Guzman-Gil E, Lopez MC, et al. Characterization of subsets of human spermatozoa at different stages of maturation: implications in the diagnosis and treatment of male infertility. Hum Reprod 2001; 16: 1912–21.
119. Saleh RA, Agarwal A, Kandirali E, et al. Leukocytospermia is associated with increased reactive oxygen species production by human spermatozoa. Fert Steril 2002; 78: 1215–24.
120. Drevet JR. The antioxidant glutathione peroxidase family and spermatozoa: a complex story. Mol Cell Endocrinol 2006; 250: 70–9.
121. Aitken RJ, Gordon E, Harkiss D, et al. Relative impact of oxidative stress on the functional competence and genomic integrity of human spermatozoa. Biol Reprod 1998; 59: 1037–46.
122. Agarwal A, Makker K, Sharma R. Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol 2008; 59: 2–11.
123. Shekarriz M, Thomas AJ Jr., Agarwal A. Incidence and level of seminal reactive oxygen species in normal men. Urology 1995; 45: 103–7.
124. Allamaneni SSR, Agarwal A, Nallela KP, et al. Characterization of oxidative stress status by a simple clinical test: evaluation of reactive oxygen species levels in whole semen and isolated spermatozoa. Fertil Steril 2005; 83: 800–3.
125. Dresdner RD, Katz DF. Relationships of mammalian sperm motility and morphology to hydrodynamic aspects of cell function. Biol Reprod 1981; 25: 920–30.
126. Mortimer ST. A critical review of the physiological importance and analysis of sperm movement in mammals. Hum Reprod Update 1997; 3: 403–39.
127. Mortimer ST, Swan MA. Variable kinematics of capacitating human spermatozoa. Hum Reprod 1995; 10: 3178–82.
128. ESHRE Andrology Special Interest Group. Guidelines on the application of CASA technology in the analysis of spermatozoa. Hum Reprod 1998; 13: 142–5.
129. Mortimer ST. CASA – practical aspects. J Androl 2000; 21: 515–24.
130. Mortimer D, Kossakowski J, Mortimer ST, Fussell S. Prediction of fertilizing ability by sperm kinematics. Abstract OC-05–043. J Ass Reprod Genet 1997; 14(5) Suppl 52S.
131. Mortimer D, Mortimer ST. Laboratory investigation of the infertile male. In: Brinsden PR, ed. A Textbook of In-Vitro Fertilization and Assisted Reproduction. 3rd edn. London: Taylor & Francis Medical Books 2005: 61–91.
132. Cummins JM, Pember SM, Jequier AM, et al. A test of the human sperm acrosome reaction following ionophore challenge: relationship to fertility and other seminal parameters. J Androl 1991; 12: 98–103.
133. Makkar G, Ng EH, Yeung WS, et al. The significance of the ionophore-challenged acrosome reaction in the prediction of successful outcome of controlled ovarian stimulation and intrauterine insemination. Hum Reprod 2003; 18: 534–9.
134. Liu DY, Stewart T, Baker HW. Normal range and variation of the zona pellucida-induced acrosome reaction in fertile men. Fertil Steril 2003; 80: 384–9.
135. Liu DY, Baker HW. Disordered zona pellucida-induced acrosome reaction and failure of in vitro fertilization in patients with unexplained infertility. Fertil Steril 2003; 79: 74–80.
136. Bastiaan HS, Menkveld R, Oehninger S, et al. Zona pellucida induced acrosome reaction, sperm morphology, and sperm-zona binding assessments among subfertile men. J Assist Reprod Genet 2002; 19: 329–34.
137. Bastiaan HS, Windt ML, Menkveld R, et al. Relationship between zona pellucidainduced acrosome reaction, sperm morphology, sperm-zona pellucida binding, and in vitro fertilization. Fertil Steril 2003; 79: 49–55.
138. World Health Organization. WHO Laboratory Manual for the Analysis of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge, UK: Cambridge University Press 1999.
139. Mortimer D, Curtis EF, Camenzind AR. Combined use of fluorescent peanut agglutinin lectin and Hoechst 33258 to monitor the acrosomal status and vitality of human spermatozoa. Hum Reprod 1990; 5: 99–103.
140. Cross NL, Morales P, Overstreet JW, Hanson FW. Two simple methods for detecting acrosome-reacted human sperm. Gamete Res 1986; 15: 213–26.
141. Talbot P, Chacon R. A new procedure for rapidly scoring acrosome reactions of human sperm. Gamete Res 1980; 3: 211–6.
142. Mortimer D. Practical Laboratory Andrology. New York: Oxford University Press 1994.
143. Burkman LJ, Coddington CC, Franken DR, et al. The hemizona assay (HZA): development of a diagnostic test for binding of human spermatozoa to the human zona pellucida to predict fertilization potential. Fertil Steril 1988; 49: 688–93.
144. Franken DR, Oehninger S, Burkman LJ, et al. The hemizona assays (HZA): a predictor of human sperm fertilizing potential in in vitro fertilization (IVF) treatment. J in Vitro Fertil Embryo Transf 1989; 6: 44–9.
145. Liu DY, Lopata A, Johnston WIH, Baker HWG. A human sperm-zona pellucida binding test using oocytes that failed to fertilize in vitro. Fertil Steril 1988; 50: 782–8.
146. Franken DR, Kruger TF, Menkveld R, et al. Hemizona assay and teratozoospermia: increasing sperm insemination concentrations to enhance zona pellucida binding. Fertil Steril 1990; 54: 497–503.
147. Menkveld R, Franken DR, Kruger TF, et al. Sperm selection capacity of the human zona pellucida. Mol Reprod Dev 1991; 30: 346–52.
148. Franken DR, Oehninger S. The clinical significance of sperm-zona pellucida binding: 17 years later. Front Biosci 2006; 1: 1227–33.
149. Oehninger S, Franken DR, Sayed E, et al. Sperm function assays and their predictive value for fertilization outcome in IVF therapy: a meta-analysis. Hum Reprod Update 2000; 6: 160–8.
150. Rubes J, Selevan SG, Sram RJ, et al. GSTM1 genotype influences the susceptibility of men to sperm DNA damage associated with exposure to air pollution. Mutat Res 2007; 625: 20–8.
151. Steele EK, McClure N, Maxwell RJ, Lewis SE. A comparison of DNA damage in testicular and proximal epididymal spermatozoa in obstructive azoospermia. Mol Hum Reprod 1999; 5: 831–5.
152. Lewis SEM, O’Connell M, Stevenson M, et al. An algorithm to predict pregnancy in assisted conception. Mol Hum Reprod 2004; 19: 1385–90.
153. Greco E, Scarselli F, Iacobelli M, et al. Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod 2005; 20: 226–30.
154. Ollero M, Gil-Guzman E, Lopez MC, et al. Characterization of subsets of human spermatozoa at different stages of maturation: implications in the diagnosis and treatment of male infertility. Hum Reprod 2001; 16: 1912–21.
155. Suganuma R, Yanagimachi R, Meistricht M. Decline in fertility of mouse sperm with abnormal chromatin during epididymal passage as revealed by ICSI. Hum Reprod 2005; 20: 3101–8.
156. Cui J, Holmes EH, Greene TG, Liu PK. Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J 2000; 14: 955–67.
157. Sergerie M, Laforest G, Bujan L, et al. Sperm DNA fragmentation: threshold value in male fertility. Hum Reprod 2005; 20: 3446–51.
158. Evenson DP, Jost LK, Marshall D, et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. Hum Reprod 1999; 14: 1039–49.
159. Fernandez JL, Vazquez-Gundin F, Delgado A, et al. DNA breakage detection-FISH (DBD-FISH) in human spermatozoa: technical variants evidence different structural features. Mutat Res 2000; 453: 77–82.
160. Fernandez JL, Muriel L, Rivero MT, et al. The sperm chromatin dispersion test: a simple method for the determination of sperm DNA fragmentation. J Androl 2003; 24: 59–66.
161. Manicardi GC, Bianchi PG, Pantano S, et al. Presence of endogenous nicks in DNA of ejaculated human spermatozoa and its relationship to chromomycin A3 accessibility. Biol Reprod 1995; 52: 864–7.
162. Singh N, MacCoy M, Tice R, et al. A simple technique for the quantification of low levels of DNA damage in individual cells. Exp Cell Res 1998; 15: 1338–44.
163. Singh N, Danner D, Tice R, et al. Abundant alkali-sensitive sites in DNA of human and mouse sperm. Exp Cell Res 1989; 184: 461–70.
164. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993; 53: 945–51.
165. Duran EH, Morshedi M, Taylor S, Oehninger S. Sperm DNA quality predicts intrauterine insemination outcome: a prospective cohort study. Hum Reprod 2002; 17: 3122–8.
166. Alvarez JG. Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod 2005; 20: 2031–2.
167. Borini A, Tarozzi N, Bizarro D, et al. Sperm DNA fragmentation: paternal effect on early post-implantation embryo development in ART. Hum Reprod 2006; 21: 2876–81.
168. Muriel L, Meseguer M, Fernandez JL, et al. Value of the sperm chromatin dispersion test in predicting pregnancy outcome in intrauterine insemination: a blind prospective study. Hum Reprod 2006; 21: 738–44.
169. Negoescu A, Guillermet C, Lorimier P, et al. Importance of DNA fragmentation in apoptosis with regard to TUNEL specificity. Biomed Pharmacother 1998; 52: 252–8.
170. Evenson DP, Wixon R. Data analysis of two in vivo fertility studies using Sperm Chromatin Structure Assay-derived DNA fragmentation index vs. pregnancy outcome. Fertil Steril 2008; 90: 1229–31.
171. Wyrobek AJ, Eskenazi B, Young S, et al. Advancing age has differential effects on DNA damage, chromatin integrity, gene mutations, and aneuploidies in sperm. Proc Natl Acad Sci 2006; 103: 9601–6.
172. Alvarez JG, Ollero M, Larson-Cook KL, Evenson DP. Selecting cryopreserved semen for assisted reproductive techniques based on the level of sperm nuclear DNA fragmentation resulted in pregnancy. Fertil Steril 2004; 81: 712–3.
173. Werthman P, Wixon R, Kasperson K, Evenson DP. Significant decrease in sperm deoxyribonucleic acid fragmentation after varicocelectomy. Fertil Steril 2008; 90: 1800–4.
174. De Jonge CJ, Centola GM, Reed ML, et al. Human sperm survival assay as a bioassay for the assisted reproductive technologies laboratory. J Androl 2003; 24: 16–8.
175. Claassens OE, Wehr JB, Harrsion KL. Optimizing sensitivity of the human sperm motility assay for embryo toxicity testing. Hum Reprod 2000; 15: 1586–91.
176. Coccia ME, Becattini C, Criscuoli L, et al. A sperm survival test and in-vitro fertilization outcome in the presence of male factor infertility. Hum Reprod 1997; 12: 1969–73.
177. Mortimer D, Curtis EF, Camenzind AR, Tanaka S. The spontaneous acrosome reaction of human spermatozoa incubated in vitro. Hum Reprod 1989; 4: 57–62.
178. Mortimer D. Sperm transport in the female genital tract. In: Grudzinskas JG, Yovich JL, eds. Cambridge Reviews in Human Reproduction. Volume 2: Gametes – The Spermatozoon. Cambridge: Cambridge University Press 1995; 157–74.
179. Mortimer ST. A critical review of the physiological importance and analysis of sperm movement in mammals. Hum Reprod Update 1997; 3: 403–39.
180. World Health Organization. WHO Laboratory Manual for the Analysis of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge: Cambridge University Press 1999.
181. Mortimer D. Practical Laboratory Andrology. New York: Oxford University Press 1994.
182. Hunault CC, Habbema JD, Eijkemans MJ, et al. Two new prediction rules for spontaneous pregnancy leading to live birth among subfertile couples, based on the synthesis of three previous models. Hum Reprod 2004; 19: 2019–26.
183. Kremer, J. A simple sperm penetration test. Int J Fertil 1965; 10: 209–14.
184. Eggert-Kruse W, Leinhos G, Gerhard, I, et al. Prognostic value of in vitro sperm penetration into hormonally standardized human cervical mucus. Fertil Steril 1989; 51: 317–23.
185. Kremer J. The in vitro spermatozoal penetration test in fertility investigations. MD thesis. Groningen, Rijksuniversiteit te Groningen, 1968.
186. Kremer J, Jager S, van Slochteren-Draaisma T. The “unexplained” poor post-coital test. Int J Fertil 1978; 23: 277–81.
187. Pandya IJ, Mortimer D, Sawers RS. A standardized approach for evaluating the penetration of human spermatozoa into cervical mucus in vitro. Fertil Steril 1986; 45: 357–65.
188. Makler A. A new method for evaluating cervical penetrability using daily aspirated and stored cervical mucus. Fertil Steril 1976; 27: 533–40.
189. Insler V, Melmed H, Eichenbrenner I, et al. The cervical score: a simple quantitative method for monitoring of the menstrual cycle. Int J Gynaecol Obstet 1972; 10: 223–8.
190. World Health Organization. WHO Laboratory Manual for the Analysis of Human Semen and Sperm-Cervical Mucus Interaction. 3rd edn. Cambridge: Cambridge University Press 1992.
191. Moghissi KS. Postcoital test: physiologic basis, technique and interpretation. Fertil Steril 1976; 27: 117–29.
192. Drobnis EZ, Yudin AL, Cherr GN, Katz DF. Hamster sperm penetration of the zona pellucida: kinematic analysis and mechanical implications. Devel Biol 1988; 130: 311–23.
193. Kurzrok R, Miller EG. Biochemical studies of human semen and its relation to mucus of the cervix uteri. Am J Obstet Gynecol 1928; 15: 56–72.
194. Katz DF, Overstreet, JW, Hanson FW. A new quantitative test for sperm penetration into cervical mucus. Fertil Steril 1980; 33: 179–86.
195. Kremer J, Jager S. The sperm-cervical mucus contact test. A preliminary report. Fertil Steril 1976; 27: 335–40.
196. Mortimer D, Mortimer ST, Shu MA, Swart R. A simplified approach to sperm-cervical mucus interaction using a hyaluronate migration test. Hum Reprod 1990; 5: 835–41.
197. Aitken RJ, Bowie H, Buckingham D, et al. Sperm penetration into a hyaluronic acid polymer as a means of monitoring functional competence. J Androl 1992; 13: 44–54.
198. Neuwinger J, Cooper TG, Knuth UA, Nieschlag E. Hyaluronic acid as a medium for human sperm migration tests. Hum Reprod 1991; 6: 396–400.
199. Yanagimachi R. Mammalian fertilization. In: Knobil E, Neill JD, eds. The Physiology of Reproduction. 2nd edn. New York: Raven Press 1994: 189–317.
200. Mortimer D. Sperm preparation methods. J Androl 2000; 21: 357–66.
201. Rogers BJ, Perreault SD, Bentwood BJ, et al. Variability in the human-hamster in vitro assay for fertility evaluation. Fertil Steril 1983; 39: 204–11.
202. Kanwar KC, Yanagimachi R, Lopata A. Effects of human seminal plasma on fertilizing capacity of human spermatozoa. Fertil Steril 1979; 31: 321–7.
203. Mortimer, D. Sperm recovery techniques to maximize fertilizing capacity. Reprod Fertil Devel 1994; 6: 25–31.
204. Mortimer D. Practical Laboratory Andrology. New York: Oxford University Press 1995.
205. Jeulin C, Serres C, Jouannet P. The effects of centrifugation, various synthetic media and temperature on the motility and vitality of human spermatozoa. Reprod Nutr Dévélop 1982; 22: 81–91.
206. Friedman AJ, Juneau-Norcross M, Sedensky B. Antisperm antibody production following intrauterine insemination. Hum Reprod 1991; 6: 1125–8.
207. Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil 1987; 81: 459–69.
208. Aitken RJ, Clarkson JS. Significance of reactive oxygen species and antioxidants in defining the efficacy of sperm preparation techniques. J Androl 1988; 9: 367–76.
209. Selley ML, Lacey MJ, Bartlett MR, et al. Content of significant amounts of a cytotoxic end-product of lipid peroxidation in human semen. J Reprod Fertil 1991; 92: 291–8.
210. Aitken RJ, Gordon E, Harkiss D, et al. Relative impact of oxidative stress on the functional competence and genomic integrity of human spermatozoa. Biol Reprod 1998; 59: 1037–46.
211. Aitken RJ. Free radicals, lipid peroxidation and sperm function. Reprod Fertil Devel 1995; 7: 659–68.
212. Mortimer D. Sperm preparation techniques and iatrogenic failures of in-vitro fertilization. Hum Reprod 1991; 6: 173–6.
213. Katz DF, Morales P, Samuels SJ, Overstreet JW. Mechanisms of filtration of morphologically abnormal human sperm by cervical mucus. Fertil Steril 1990; 54: 513–6.
214. Mortimer, D. Sperm transport in the female genital tract. In: Grudzinskas JG, Yovich JL, eds. Cambridge Reviews in Human Reproduction. Volume 2: Gametes – The Spermatozoon. Cambridge (UK): Cambridge University Press 1995: 157–74.
215. Mortimer ST. A critical review of the physiological importance and analysis of sperm movement in mammals. Hum Reprod Update 1997; 3: 403–39.
216. Tea NT, Jondet M, Scholler R. A ‘migrationgravity sedimentation’ method for collecting motile spermatozoa from human semen. In: Harrison RF, Bonnar J, Thompson W, eds. In Vitro Fertilization, Embryo Transfer and Early Pregnancy. Lancaster (UK): MTP Press Ltd. 1984: 117–20.
217. Sherman JK, Paulson JD, Liu KC. Effect of glass wool filtration on ultra structure of human spermatozoa. Fertil Steril 1981; 36: 643–7.
218. Gellert-Mortimer ST, Clarke GN, Baker HWG, et al. Evaluation of Nycodenz and Percoll density gradients for the selection of motile human spermatozoa. Fertil Steril 1988; 49: 335–41.
219. Sbracia M, Sayme N, Grasso J, et al. Sperm function and choice of preparation media: comparison of Percoll and Accudenz discontinuous density gradients. J Androl 1996; 17: 61–7.
220. Smith TT, Byers M, Kaftani D, Whitford W. The use of iodixanol as a density gradient material for separating human sperm from semen. Arch Androl 1997; 38: 223–30.
221. Oshio S, Kaneko S, Iizuka R, Mohri H. Effects of gradient centrifugation on human sperm. Arch Androl 1987; 17: 85–93.
222. World Health Organization. WHO Laboratory Manual for the Analysis of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge (UK): Cambridge University Press 1999.
223. Sakkas D, Manicardi GC, Tomlinson M, et al. The use of two density gradient centrifugation techniques and the swim-up method to separate spermatozoa with chromatin and nuclear DNA anomalies. Hum Reprod 2000; 15: 1112–6.
224. Tomlinson MJ, Moffatt O, Manicardi GC, et al. Interrelationships between seminal parameters and sperm nuclear DNA damage before and after density gradient centrifugation: implications for assisted conception. Hum Reprod 2001; 16: 2160–5.
225. Shoukir Y, Chardonnens D, Campana A, Sakkas D. Blastocyst development from supernumerary embryos after intracytoplasmic sperm injection: a paternal influence? Hum Reprod 1998; 13: 1632–7.
226. Shalgi R, Smith TT, Yanagimachi R. A quantitative comparison of the passage of capacitated and uncapacitated hamster spermatozoa through the uterotubal junction. Biol Reprod 1992; 46: 419–24.
227. de Ziegler D, Cedars MI, Hamilton F, et al. Factors influencing maintenance of sperm motility during in vitro processing. Fertil Steril 1987; 48: 816–20.
228. Knuth UA, Neuwinger J, Nieschlag E. Bias to routine semen analysis by uncontrolled changes in laboratory environment – detection by long-term sampling of monthly means for quality control. Int J Androl 1989; 12: 375–83.
229. Wolf DP, Byrd W, Dandekar P, Quigley MM. Sperm concentration and the fertilization of human eggs in vitro. Biol Reprod 1984; 31: 837–48.
230. Mortimer D, Mortimer ST. Quality and Risk Management in the IVF Laboratory. Cambridge (UK): Cambridge University Press 2005.
231. Cryo Bio System. Fundamentals of Cryobiology. Paris: Cryo Bio System 2006. www.cryobiosystem-imv.com/Cryobiology/Basesfondamentalesdelacryobiologie/tabid/251/Default.aspx (viewed 10/08/2008).
232. Fuller B, Paynter S. Fundamentals of cryobiology in reproductive medicine. Reprod Biomed Online 2004; 9: 680–91.
233. Mazur P, Leibo SP, Farrant J, et al. Interactions of cooling rate, warming rate and protective additive on the survival of frozen mammalian cells. In: Wolstenholme GE, O’Connor M, eds. The Frozen Cell. London: Churchill Press 1970: 69–88.
234. Nei T. Mechanism of haemolysis of erythrocytes by freezing, with special reference to freezing at near-zero temperatures. In: Wolstenholme GE, O’Connor M, eds. The Frozen Cell. London: Churchill Press 1970: 131–47.
235. Merryman HT. The exceeding of a minimum tolerable cell volume in hypertonic suspension as a cause of freezing injury. In: Wolstenholme GE, O’Connor M, eds. The Frozen Cell. London: Churchill Press 1970: 565–9.
236. Nijs M, Ombelet W. Cryopreservation of human sperm. Hum Fertil 2001; 4: 158–63.
237. Gao D, Liu J, Liu C, et al. Prevention of osmotic injury to human spermatozoa during addition and removal of glycerol. Hum Reprod 1995; 10: 1109–22.
238. Gilmore JA, Liu J, Gao DY, et al. Determination of optimal cryoprotectants and procedures for their addition and removal from human spermatozoa. Hum Reprod 1997; 12: 112–8.
239. Mortimer D. Practical Laboratory Andrology. Oxford:OxfordUniversity Press 1994: 301–23.
240. Centola GM, Raubertas RF, Mattox JH. Cryopreservation of human semen. Comparison of cryopreservatives, sources of variability, and prediction of post-thaw survival. J Androl 1992; 13: 283–8.
241. Keel BA, Webster BW. Semen cryopreservation methodology and results. In: Barrat CLR, Cooke ID, eds. Donor insemination. Cambridge: Cambridge University Press 1993: 96–71.
242. Barrat CL, Clements S, Kessopoulou E. Semen characteristics and fertility tests required for storage of spermatozoa. Hum Reprod 1998; 13 Suppl 2: 1–7.
243. Yogev L, Kleiman S, Shabtai E, et al. Seasonal variations in pre- and post-thaw donor sperm quality. Hum Reprod 2004; 19: 880–5.
244. Holt WV. Basic aspects of frozen storage of semen. Anim Reprod Sci, 2000; 62: 3–22.
245. Stacey G. Validation of cell culture media components. Hum Fertil 2004; 7: 113–8.
246. Nallella KP, Sharma KK, Allamaneni SS, et al. Cryopreservation of human spermatozoa: comparison of two cryopreservation methods and three cryoprotectants. Fertil Steril 2004; 82: 913–8.
247. Mortimer D. Current and future concepts and practices in human sperm cryobanking. Reprod Biomed Online 2004; 9: 134–51.
248. Stanic P, Tandara M, Sonicki Z, et al. Comparison of protective media and freezing techniques for cryopreservation of human semen. Eur J Obstet Gynecol Reprod Biol 2000; 91: 65–70.
249. Morris J. Asymptote Cool Guide to Cryopreservation 2002. Cambridge: Asymptote Ltd.: 49. www.asymptote.co.uk/cryo/CoolGuid.pdf (viewed 06/04/2008).
250. Henry MA, Noiles EE, Gao D, et al. Cryopreservation of human spermatozoa. IV. The effects of cooling rate of warming rate on the maintenance of motility, plasma membrane integrity, and mitochondrial function. Fertil Steril 1993; 60: 911–8.
251. Isachenko V, Isachenko E, Katkov II, et al. Cryoprotectant-free cryopreservation of human spermatozoa by vitrification and freezing in vapor: effect on motility, DNA integrity, and fertilization ability. Biol Reprod 2004; 71: 1167–73.
252. Cassou R. La méthode des paillettes en plastique adaptée a la généralisation de la congélation. 5th Int Cong Anim Reprod Artif Insem, Trento 1964; 4: 540–6.
253. Cryo Bio System. CBS™ High Security Cryobanking Systems Product Monograph. Paris: Cryo Bio System 2006. www.cryobiosystem-imv.com/Portals/3/PDF/Monograph.pdf (viewed 10/08/2008).
254. Russell PH, Lyaruu VH, Millar JD, et al. The potential transmission of infectious agents by semen packaging during storage for artificial insemination. Anim Reprod Sci 1997; 47: 337–42.
255. Tyler JP, Kime L, Cooke S, et al. Temperature change in cryo-containers during short exposure to ambient temperatures. Hum Reprod 1996; 11: 1510–2.
256. Byers KB. Risks associated with liquid nitrogen cryogenic storage systems. J Am Biol Safety Assoc 1998; 3: 143–6.
257. Clarke GN. Sperm cryopreservation: is there a significant risk of cross-contamination? Hum Reprod 1999; 14: 2941–3.
258. Nalge Nunc International. Cryopreservation Manual. Rochester: Nalge Nunc International Corporation 1998.
259. Wood MJ. The problems of storing gametes and embryos. Cryo-Letters 1999; 20: 155–8.
260. Tedder RS, Zuckerman MA, Goldstone AH, et al. Hepatitis B transmission from contaminated cryopreservation tank. Lancet 1995; 346: 137–40.
261. Tomlinson M, Sakkas D. Is a review of standard procedures for cryopreservation needed? Safe and effective cryopreservation – should sperm banks and fertility centres move towards storage in nitrogen vapour? Hum Reprod 2000; 15: 2460–3.
262. Mortimer D. Setting up risk management systems in IVF laboratories. Clinical Risk 2004; 10: 128–37.
263. Mortimer D, Mortimer ST. Quality and Risk Management in the IVF Laboratory. Cambridge: Cambridge University Press 2005.
264. Elder K, Baker D, Ribes J. Infections, Infertility and Assisted Reproduction. Cambridge: Cambridge University Press 2005.
265. Carrell DT, Cartmill D, Jones KP, et al. Prospective randomized, blinded evaluation of donor semen quality provided by seven commercial sperm banks. Fertil Steril 2002; 78: 16–21.
266. Castilla JA, Sánchez-León M, Garrido A, et al. Procedure control and acceptance sampling for donor sperm banks a theoretical study. Cell Tissue Bank 2007; 8: 257–65.
267. Chan CC, Chen IC, Liu JY, et al. Comparison of nitric oxide production motion characteristics of sperm after cryopreserved in three different preparations. Arch Androl 2004; 50: 1–3.
268. Grizard G, Chevalier V, Griveau JF, et al. Influence of seminal plasma on cryopreservation of human spermatozoa in a biological material-free medium: study of normal low-quality semen. Int J Androl 1999; 22: 190–6.
269. David G, Czyglik F, Mayaux MJ, et al. Artificial insemination with frozen sperm: protocol, method of analysis and results for 1188 women. Br J Obstet Gynaecol 1980; 87: 1022–8.
270. Le Lannou D, Thepot F, Jouannet P. Multicentre approaches to donor insemination in the French CECOS Federation: Nationwide evaluation donor matching, screening for genetic diseases and consanguinity. Hum Reprod 1998; 13 Suppl 2: 35–54.
271. Ofeim O, Brown TA, Gilbert BR. Effects of serial thaw-refreeze cycles on human sperm motility and viability. Fertil Steril 2001; 75: 1242–3.
272. Cohen J, Garrisi GJ, Congedo-Ferrara TA, et al. Cryopreservation of single human spermatozoa. Hum Reprod 1997; 12: 994–1001.
273. European Union. 2004 Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage, and distribution of human tissues and cells. Official Journal of the European Union 2004; L 102/48.
274. Mortimer D. A critical assessment of the impact of the European Union Tissues and Cells Directive (2004) on laboratory practices in assisted conception. Reprod Biomed Online 2005; 11: 162–76.
275. The ESRHE Task Force on Ethics and Law. Taskforce 7: Ethical considerations for the cryopreservation of gametes and reproductive tissues for self use. Hum Reprod 2004; 19: 460–2.
276. Horne G, Atkinson AD, Pease EH, et al. Live birth with sperm cryopreserved for 21 years prior to cancer treatment: case report. Hum Reprod 2004; 19: 1448–9.
277. American Society for Reproductive Medicine (ASRM). Guidelines for gamete and embryo donation. Fertil Steril 2006; 86 Suppl 1: 38–50.
278. British Andrology Society (BAS). Guidelines for the Screening of Semen Donors for Donors Insemination. London: British Andrology Society 1999.
279. Gamete donation guidelines. The Corsendonk consensus document for the European Union. Hum Reprod 1998; 13 Suppl 2: 7–12.
280. Health Canada Directive. Technical Requirements for Therapeutic Donor Insemination. July 2000 (Ottawa, Canada). Available at: www.hc-sc.gc.ca/dhp-mps/alt_formats/hpfb-dgpsa/pdf/prodpharma/semen-sperme_directive-eng.pdf (viewed 23/07/2008).
281. Donoso P, Tournaye H, Devroey P. Which is the best sperm retrieval technique for nonobstructive azoospermia? A systematic review. Hum Reprod Update 2007; 13: 539–49.
282. Wald M, Makhlouf AA, Niederberger CS. Therapeutic testis biopsy for sperm retrieval. Curr Opin Urol 2007; 17: 431–8.
283. van Peperstraten A, Proctor M, Johnson N, Philipson G. Techniques for surgical retrieval of sperm prior to intra-cytoplasmic sperm injection (ICSI) for azoospermia. Cochrane Database Syst Rev 2008; 16: CD002807.
284. Rowe PJC, Vomhaire FH, Hargreave TB, Mahmous AMA. WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. Cambridge: Cambridge University Press 2000.
285. Kovacic B, Vlaisavljevic V, Reljic M. Clinical use of pentoxifylline for activation of immotile testicular sperm before ICSI in patients with azoospermia. J Androl 2006; 27: 45–52.
286. Tournaye H, Devroey P, Camus M, et al. Use of pentoxifylline in assisted reproductive technology. HumReprod 1995; 10 Suppl 1: 72–9.
287. Tomlinson MJ, Barrat CL. Internal and external quality control in the and rology laboratory. In: Keel BA, May JV, De Jonge CJ, eds. Handbook of the Assisted Reproduction Laboratory. Boca Raton: CRC Press 2000: 269–77.
288. Centola GM. Quality control, quality assurance, and management of the cryopreservation laboratory. In: Keel BA, May JV, De Jonge CJ, eds. Handbook of the Assisted Reproduction Laboratory. Boca Raton: CRC Press 2000: 303–25.
289. Deming, WE. Out of the Crisis. Cambridge, MA: MIT Press 1986.
290. Mortimer D, Mortimer ST. Quality and Risk Management in the IVF Laboratory. Cambridge: Cambridge University Press 2005.
291. McCulloh DH. Quality control and quality assurance. Obstet Gynecol Clin N Am 1998; 9: 285–309.
292. Huysman W, Horvath AR, Burnett D, et al. Accreditation of medical laboratories in the European Union. Clin Chem Lab Med 2007; 45: 268–75.
293. Burnett D. A Practical Guide to Accreditation in Laboratory Medicine. London: ABC Venture Publications 2002.
294. Castilla JA, Hernandez J, Cabello Y, et al. Defining poor and optimum performance in an IVF programme. Hum Reprod 2008; 23: 85–90.
295. Riddell D, Pacey A, Whittington K. Lack of compliance by UK andrology laboratories with World Health Organization recommendations for sperm morphology assessment. Hum Reprod 2005; 12: 3441–5.
296. Björndahl L, Barratt CLR, Fraser LR, et al. ESHRE basic semen analysis courses 1995–1999: immediate beneficial effects of standardized training. Hum Reprod 2002; 17: 1299–305.
297. Mourad SM, Hermens RP, Nelen WL, et al. Guideline-based development of quality indicators for subfertility care. Hum Reprod 2007; 22: 2665–72.
298. Wollersheim H, Hermens R, Hulscher M, et al. Clinical indicators: development and applications. Neth J Med 2007; 65: 15–22.
299. Keck C, Fischer R, Baukloh V, et al. Staff management in the in vitro fertilization laboratory. Fertil Steril 2005; 84: 1786–8.
300. Aguilar J, Alvarez C, Morancho-Zaragoza J, et al. Quality specifications for seminal parameters based on clinicians’ opinions. Scand J Clin Lab Invest 2008; 68: 68–76.
301. Toft G, Rignell-Hydbom A, Tyrkiel E, et al. Quality control workshops in standardization of sperm concentration and motility assessment in multicentre studies. Int J Androl 2005; 28: 144–9.
302. Auger J, Eustache F, Ducot B, et al. Intra and inter-individuality variability in human sperm concentration, motility and vitality assessment during a workshop involving ten laboratories. Hum Reprod 2000; 15: 2360–8.
303. Björndahl L, Tomlinson M, Barratt CLR. Raising standards in semen analysis: Professional and personal responsibility. J Androl 2004; 25: 862–3.
304. Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med 2005; 37: 360–3.
305. Petersen PH, Stöckl D, Blaabjerg O, et al. Graphical interpretation of analytical data from comparison of a field method with reference method by use of difference plots. Clin Chem 1997; 43: 2039–46.
306. Mortimer D. Technician training and quality control aspects. In: Practical Laboratory Andrology. Oxford: Oxford University Press 1994: 337–347.
307. Menkveld R, Stander FSH, Kotze TJvW, Kruger TF, Van Zyl JA. The evaluation of morphological characteristics of human spermatozoa according to stricter criteria. Hum Reprod 1990; 5: 586–92.
308. Kruger TF, Acosta AA, Simmons KF, Swanson RJ, Matta JF, Oehninger S. Predictive value of abnormal sperm morphology in in vitro fertilization. Fertil Steril 1988; 49: 112–7.
309. Franken DR, Menkveld R, Kruger TF, Sekadde-Kigondu C, Lombard C. Monitoring technologist reading skills in a sperm morphology quality control program. Fertil Steril 2003; 79: 1637–43.
310. Alvarez C, Castilla JA, Martinez L, et al. Biological variation of seminal parameters in healthy subjects. Hum Reprod 2003; 18: 2082–8.
311. Johnson JE, Blackhurt DW, Boone WR. Can Westgard Quality Control Rules determine the suitability of frozen sperm pellets as a control material for computer assisted semen analyzers? J Assist Reprod Genet 2003; 20: 38–45.
312. Clements S, Cooke ID, Barratt CL. Implementing comprehensive quality control in the andrology laboratory. Hum Reprod 1995; 10: 2096–106.
313. Lu JC, Xu HR, Chen F, et al. Standardization and quality control for the determination of alpha-glucosidase in seminal plasma. Arch Androl 2006; 52: 447–53.
314. Fearn T, Thompson M. A new test for ‘sufficient homogeneity’. Analyst 2001; 126: 1414–7.
315. ISO. ISO 13528. Statistical Methods for Use in Proficiency Testing by Interlaboratory Comparisons. Geneva, Switzerland: International Standardization Organization 2005.
316. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989; 27: 409–37.
317. Fraser CG, Kallner A, Kenny D, Petersen PH. Introduction: strategies to set global quality specifications in laboratory medicine. Scand J Clin Lab Invest 1999; 59: 477–8.
318. Ricos C, Alvarez V, Cava F, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest 1999; 59: 491–500.
319. Castilla JA, Morancho-Zaragoza J, Aguilar J, et al. Quality specifications for seminal parameters based on the state of the art. Hum Reprod 2005; 20: 2573–8
320. Westgard JO. Use and interpretation of common statistical tests in method comparison studies. Clin Chem 2008; 54: 612.
321. Cooper TG, Atkinson AD, Nieschlag E. Experience with external quality control in spermatology. Hum Reprod 1999; 14: 765–9.
322. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 4th edn. Cambridge, UK: Cambridge University Press 1999.
323. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307–10.
324. McCulloh DH. Quality Control and Quality Assurance. Record Keeping and Impact on ART Performance and Clinical Outcome. In: May JV, Diamond MP, De Cherney AH, eds. Infertility and Reproductive Medicine: Clinics of North America 1998: 285–309.
325. Castilla JA, Sanchez-Leon M, Garrido A, et al. Procedure control and acceptance sampling plans for donor sperm banks: a theoretical study. Cell Tissue Bank 2007; 8(4): 257–65.
326. Alvarez C, Castilla JA, Ramirez JP, et al. External quality control program for semen analysis: Spanish experience. J Assist Reprod Genet 2005; 22: 379–87.
327. Strike PW. Statistical Methods in Laboratory Medicine. Oxford: Butterworth Heinemann 1991.
328. Jequier AM, Ukombe EB. Errors inherent in the performance of a routine semen analysis. Br J Urol 1983; 55: 434–6.
329. Neuwinger J, Behre HM, Nieschlag E. External quality control in the andrology laboratory: an experimental multicenter trail. Fertil Steril 1990; 54: 308–14.
330. Matson PL. External quality assessment for semen analysis and sperm antibody detection: results of a pilot scheme. Hum Reprod 1995; 10: 620–5.
331. Keel BA, Quinn P, Schmidt CF Jr., et al. Results of the American Association of Bioanalysts national proficiency testing program in andrology. Hum Reprod 2000; 15: 680–6.
332. Eliasson R. Standards for investigation of human semen. Andrologie 1971; 3: 49–64.
333. Eliasson R. Analysis of semen. In: Burger H, de Kretser D, eds. The Testis. New York: Raven Press 1981: 381–99.
334. Mortimer, D. Laboratory standards in routine clinical andrology. Reprod Med Rev 1994; 3: 97–111.
335. Belsey MA, Eliasson R, Gallegos AJ, et al. Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. Singapore: Press Concern 1980.
336. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus Interaction. 2nd edn. Cambridge: Cambridge University Press 1987.
337. World Health Organization. WHO Laboratory Manual for the Examination of Human Semen and Sperm-Cervical Mucus Interaction. 3rd edn. Cambridge: Cambridge University Press 1992.
338. Yeung CH, Cooper TG, Nieschlag E. A technique for standardization and quality control of subjective sperm motility assessments in semen analysis. Fertil Steril 1997; 67: 1156–8.
339. International Standard ISO 15189. Medical laboratories – Particular Requirements for Quality and Competence. Geneva: International Organization for Standardization 2007.
340. ISO. Guide to the Expression of Uncertainty in Measurement. Geneva: International Organization for Standardization 1993.
341. Cook RR. Assessment of Uncertainties in Measurement for Calibration and Testing Laboratories. Sydney: National Association of Testing Authorities 1999.
342. Matson PL. External quality assessment for semen analysis and sperm antibody detection: Results of a pilot scheme. Hum Reprod 1995; 10: 620–5.
343. Cooper TG, Björndahl L, Vreeburg J, et al. Semen analysis and external quality control schemes for semen analysis need global standardization. Int J Androl 2002; 25: 306–11.
344. Mortimer D. A critical assessment of the impact of the European Union Tissues and Cells Directive (2004) on laboratory practices in assisted conception. Reprod Biomed Online 2005; 11: 162–76.
345. Hartshorne GM. Challenges of the EU ‘tissues and cells’ directive. Reprod Biomed Online 2005; 11: 404–7.
346. European Society of Human Reproduction and Embryology. ESHRE position paper on the EU Tissues and Cells Directive EC/2204/23, November 2007. http://www. eshre.com/emc.asp?pageId=685 (viewed 01/08/2008).
347. Carrell DT, Cartmill D. A brief review of current and proposed federal government regulation of assisted reproduction laboratories in the United States. J Androl 2006; 23: 611–7.
348. Mortimer D, Mortimer ST. Quality and Risk Management in the IVF Laboratory. Cambridge: Cambridge University Press 2005.
349. Kennedy CR. Risk management in assisted reproduction. Clin Risk 2004; 10: 169–75.
350. Kennedy CR, Mortimer D. Risk management in IVF. Best Pract Res Clin Obstet Gynaecol 2007; 21: 691–712.
351. Mortimer D. Setting up risk management systems in IVF laboratories. Clin Risk 2004; 10: 128–37.
352. Hutchison D. Total Quality Management in the Clinical Laboratory. Milwaukee: ASQC Quality Press 1994.
353. Reason JT. Foreword. In: Bogner MS, ed. Human Error in Medicine. Hillsdale: Lawrence Erlbaum Associates Inc. 1994.
354. Bogner MS, ed. Human Error in Medicine. Hillsdale: Lawrence Erlbaum Associates Inc. 1994.
355. Leape LL. A systems analysis approach to medical error. J Eval Clin Pract 1997; 3: 213–22.
356. International Standard ISO 15189. Medical Laboratories – Particular Requirements for Quality and Competence. Geneva: International Organization for Standardization 2007.
357. Burnett D. A Practical Guide to Accreditation in Laboratory Medicine. London: ACB Venture Publications 2002.
358. Mortimer D, Barratt CLR. Is there a real risk of transmitting variant Creutzfeldt–Jakob Disease (vCJD) by donor sperm insemination? Reprod Biomed Online 2006; 13: 778–90.
359. DeMarco T Slack. Getting Past Burnout, Busywork, and the Myth of Total Efficiency. New York: Broadway Books 2001.
360. Brison DR, Hooper M, Critchlow JD, et al. Reducing risk in the IVF laboratory: implementation of a double-witnessing system. Clin Risk 2004; 10: 176–80.
361. Tomlinson M, Morroll D. Risks associated with cryopreservation: a survey of assisted conception units in the UK and Ireland. Hum Fertil 2008; 11: 33–42.
362. Tomlinson M. Managing risk associated with cryopreservation. Hum Reprod 2005; 20: 1751–6.
363. Clarke G. Sperm cryopreservation: is there a significant risk of cross-contamination? Hum Reprod 1999; 14: 2941–3.
364. Air Liquide – DMC. Cryogenic Material: Safety in Cryogenics. Bussy-Saint-Georges: Air Liquide – DMC 2008. www.dmc.airliquide.com/en/precautions/precaution.htm (viewed 05/12/2008).
365. Mortimer D. A critical assessment of the impact of the European Union Tissues and Cells Directive (2004) on laboratory practices in assisted conception. Reprod Biomed Online 2005; 11: 162–76.
366. Mortimer D. Current and future concepts and practices in human sperm cryobanking. Reprod Biomed Online 2004; 9: 134–51.
367. Nallella KP, Sharma RK, Aziz N, Agarwal A. Significance of sperm characteristics in the evaluation of male infertility. Fertil Steril 2006; 85: 629–34.
368. Jedrzejczak P, Taszarek-Hauke G, Hauke J, Pawelczyk L, Duleba AJ. Prediction of spontaneous conception based on semen parameters. Int J Androl 2008; 31: 499–507.
369. Jequier AM. The importance of diagnosis in the clinical management of infertility in the male. Reprod Biomed Online 2006; 13: 331–5.
370. Mortimer, D. Structured management as a basis for cost-effective infertility care. In: Gagnon C, ed. The Male Gamete: From Basic Knowledge to Clinical Applications. Vienna, IL: Cache River Press 1999: 363–370.
371. Mortimer, D. The future of male infertility and ART. Hum Reprod 2000; 16 Suppl 5: 98–110.
372. Phillips KP, Tanphaichitr N. Human exposure to endocrine disrupters and semen quality. J Toxicol Environ Health B Crit Rev 2008; 11: 188–220.
373. Kumar S. Occupational exposure associated with reproductive dysfunction. J Occup Health 2004; 46: 19.
374. Brazil C, Shanna SH, Tollner CR, et al. Study for Future Families Research Group. Quality control of laboratory methods for semen evaluation in a multicenter research study. J Androl 2004; 25: 645–56.
375. Cooper TG, Brazil C, Swan SH, Overstreet JW. Ejaculate volume is seriously underestimated when semen is pipetted or decanted into cylinders from the collection vessel. J Androl 2007; 28: 1–4.
376. Brazil C, Swan SH, Drobnis EZ, et al. Study for Future Families Research Group. Standardized methods for semen evaluation in a multicenter research study. J Androl 2004; 25: 635–44.
377. Haugen TB. In search of an accurate and rapid method for sperm counting. Scand J Clin Lab Invest 2007; 67: 436–8.
378. Tomlinson M, Turner J, Powell G, Sakkas D. One-step disposable chambers for sperm concentration and motility assessment: how do they compare with the World Health Organization's recommended methods? Hum Reprod 2001; 16: 121–4.
379. Douglas-Hamilton DH, Smith NG, Kuster CE, et al. Capillary-loaded particle fluid dynamics: effect on estimation of sperm concentration. J Androl 2005; 26: 115–22.
380. Stokes-Riner A, Thurston SW, Brazil C, et al. One semen sample or 2? Insights from a study of fertile men. J Androl 2007; 28: 38–43.
381. Jørgensen N, Auger J, Giwercman A, et al. Semen analysis performed by different laboratory teams: an intervariation study. Int J Androl 1997; 20: 201–8.
382. Auger J, Eustache F, Ducot B, et al. Intra-and inter-individual variability in human sperm concentration, motility and vitality assessment during a workshop involving ten laboratories. Hum Reprod 2000; 15: 2360–8.
383. Björndahl L, Barratt CL, Fraser LR, et al. ESHRE basic semen analysis courses 1995–1999: immediate beneficial effects of standardized training. Hum Reprod 2002; 17: 1299–305.
384. Perreault SD, Aitken RJ, Baker HW, et al. Integrating new tests of sperm genetic integrity into semen analysis: breakout group discussion. Adv Exp Med Biol 2003; 518: 253–68.
385. Chohan KR, Griffin JT, Lafromboise M, et al. Comparison of chromatin assays for DNA fragmentation evaluation in human sperm. J Androl 2006; 27: 53–9.
386. Evenson DP, Wixon R. Environmental toxicants cause sperm DNA fragmentation as detected by the Sperm Chromatin Structure Assay (SCSA®). Toxicol Appl Pharmacol 2005; 207: 532–7.
387. Fernández JL, Muriel L, Rivero MT, et al. The sperm chromatin dispersion test: a simple method for the determination of sperm DNA fragmentation. J Androl 2003; 24: 59–66.